EyePoint Pharmaceuticals, Inc. (EYPT) vs OraSure Technologies, Inc. (OSUR)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and OraSure Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.19HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
OSUR
OraSure Technologies, Inc.
$3.86HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — EYPT vs OSUR
growth of $100 · dividends reinvested · last 10yEYPT -86.8% (-18.3%/yr)OSUR -48.7% (-6.5%/yr)OSUR compounded faster over this window
EYPT OSUR
EYPT vs OSUR: by the numbers
- •EYPT is the larger company ($267M vs $265M market cap).
- •Both run net losses; OSUR's is the smaller (-43.70% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; OSUR's decline was smaller (-13.12% vs -41.05% CAGR).
Metrics side by side
Valuation
| Metric | EYPT | OSUR |
|---|---|---|
| P/S ratio | 95.75 | 2.36 |
| P/B ratio | 1.60 | 0.84 |
Profitability
| Metric | EYPT | OSUR |
|---|---|---|
| Gross margin | 93.41% | 41.38% |
| Operating margin | -775.98% | -59.23% |
| Net margin | -10994.73% | -43.70% |
| ROE | -184.27% | -15.46% |
| ROIC | -170.19% | -15.00% |
Growth (annualized)
| Metric | EYPT | OSUR |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | -13.12% |
| Total return CAGR (5Y) | -21.68% | -17.56% |
Frequently asked
- Which has grown faster, EYPT or OSUR?
- Neither grew: over the past five years both shrank revenue, with OSUR's decline the smaller — EYPT at a -41.05% CAGR versus OSUR at -13.12%.
- How have EYPT and OSUR total returns compared?
- Over the past 10 years, EYPT delivered -20.02% and OSUR delivered -6.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.